1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel technique for performing simultaneous dual radiotracer imaging studies in PET: A proof of principle using (18)FMISO) and (18)FLT
    Meeting Abstract

    Schwartz, J.; Zanzonico, P.; Longo, V.; Veach, D.; Nehmeh, S.; Humm, J.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Does liver tumor burden affect the therapeutic effect of (177)Lu-dotate treatment? Analysis of progression free survival, safety and quality of life in NETTER-1 study
    Meeting Abstract

    Strosberg, J.; Hendifar, A.; Yao, J.; Kulke, M.; O'Dorisio, T.; Kunz, P.; Hobday, T.; Mittra, E.; Santoro, P.; Bodei, L.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Preclinical development and first-in-human imaging of 89Zr-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Burnazi, E.; Staton, K.; Weber, W.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • A rapid bead based radioimmunoassay for the determination of target binding fraction and quality control of radiopharmaceuticals
    Meeting Abstract

    Sharma, S. K.; Lyashchenko, S.; Park, H.; Roux, Y.; Pillarsetty, N. V. K.; Poty, S.; Tully, K.; Poirier, J.; Lewis, J.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • 89Zr-trastuzumab PET/CT for prediction of response to HER2-targeted therapy in patients with HER2 mutant lung cancer: An exploratory phase 2 trial
    Meeting Abstract

    Ulaner, G.; Offin, M.; Scaltriti, M.; Myers, M.; Venkatesh, A.; Panora, E.; Kris, M.; Rudin, C.; Arcila, M.; Lyashchenko, S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • PET imaging of recurrent brain tumors using (18)F-FACBC
    Meeting Abstract

    Michaud, L.; Beattie, B.; Lassman, A. B.; Zanzonico, P.; Akhurst, T. J.; Ronald, D. F.; Audrey, M.; Larson, S.; Schoder, H.; Weber, W. A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Post-treatment 18F-FDG PET/CT surveillance for detection of recurrence in stage III Merkel cell carcinoma
    Meeting Abstract

    Mahajan, S.; Barker, C.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Results from the OSPREY trial: A Prospective phase 2/3 multi-center study of (18)F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy
    Meeting Abstract

    Rowe, S.; Gorin, M.; Pienta, K.; Siegel, B.; Carroll, P.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M.; Alva, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Histologically-confirmed diagnostic efficacy of (18)F-rhPSMA-7 positron emission tomography for N-staging of patients with high risk primary prostate cancer
    Meeting Abstract

    Kroenke, M.; Wurzer, A.; Schwamborn, K.; Ulbrich, L.; Jooay, L.; Maurer, T.; Horn, T.; Kropf, S.; Haller, B.; Wester, H.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Selection and radiolabeling of bicyclam analogues for Imaging CXCR4 expression in gliomas (GBM) and primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Maeda, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save